| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/17/2005 | CN1655770A Chewable soft capsule |
| 08/17/2005 | CN1654477A Process for preparing transfer factor-heating method |
| 08/17/2005 | CN1654072A Immunoglobulin for dog intravenous injection, its preparing method and the formulation thereof |
| 08/17/2005 | CN1215167C Helicobacter pylori live vaccine |
| 08/17/2005 | CN1215082C Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses |
| 08/17/2005 | CN1214802C Capsule for curing acne and its preparation process |
| 08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
| 08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
| 08/16/2005 | US6930118 3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 08/16/2005 | US6930111 Substituted heterocyclic compounds |
| 08/16/2005 | US6930101 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/16/2005 | US6929932 An isolated polynucleotide molecule encoding an IL-21 antagonist polypeptide of specefic amino acid sequence; culturing |
| 08/16/2005 | US6929798 Compositions and methods for treatment of microbial infections |
| 08/16/2005 | US6929793 Nutritional composition for treating an immune condition |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2166059C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/16/2005 | CA2157500C Lo-cd2a antibody and uses thereof for inhibiting t-cell activation and proliferation |
| 08/16/2005 | CA2098533C Carrier system against gnrh |
| 08/11/2005 | WO2005072684A1 Process for producing maca extract |
| 08/11/2005 | WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof |
| 08/11/2005 | US20050177876 Fcyriia transgenic animal model for autoimmune disease |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176931 Eotaxin : eosinophil chemotactic cytokine |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176825 a mixture of quinic acid and salts, and nontoxic inert carriers or diluents; solvent extraction |
| 08/11/2005 | US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis |
| 08/11/2005 | US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders |
| 08/11/2005 | US20050176815 Malaria therapy |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2005 | US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/11/2005 | US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176751 Selective H1 histamine receptor antagonists; bronchial asthma, allergic rhinitis, conjunctivitis, dermatitis, urticaria and other allergic diseases; e.g. 3-(4-[1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]piperidin-1-ylmethyl)benzoic acid |
| 08/11/2005 | US20050176732 Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176722 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/11/2005 | US20050176715 Piperidine derivatives |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176711 Phthalazine derivatives for treating inflammatory diseases |
| 08/11/2005 | US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 08/11/2005 | US20050176704 Hydroxymorpholinone derivative and medicinal use thereof |
| 08/11/2005 | US20050176700 (2-methoxyphenyl)acetic acid-7-{4-[3-(2-methoxybenzyloxy)-propoxy]phenyl}-3-(2-thiophen-2-ylacetyl)-3,9-diazabicyclo[3.3.1]non-6-en-6-yl-methyl ester; metabolically stable, orally bioavailable and sufficiently soluble; industrial scale; non-peptidic nature, low molecular weight |
| 08/11/2005 | US20050176694 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 08/11/2005 | US20050176687 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 08/11/2005 | US20050176678 Compounds and method for coating surfaces in a haemocompatibe manner |
| 08/11/2005 | US20050176672 Use of cationic lipids to generate anti-tumor immunity |
| 08/11/2005 | US20050176640 poxvirus protein A41L binds to leukocyte common-antigen-related protein; monoclonal antibody; therapeutic agents for an immune and/or inflammatory response; poxvirus |
| 08/11/2005 | US20050176123 Protease inhibitor |
| 08/11/2005 | US20050176094 Polypeptide having immunomodulatory activity, antiviral activity, and antitumor activity; polynucleotides, expression vectors , probes and antibodies; predicting responsiveness to treatment with interferon- alpha and other interferons which act at the Type 1 interferon receptor |
| 08/11/2005 | US20050175724 Composition for modulating at least one physiological reaction or inducing an immune response in human or animal after oral administration; for intestinal delivery of a physiologically active agent, a neutralizing agent, an inhibitor of digestive enzymes, an uptake increasing agent; synergistic |
| 08/11/2005 | US20050175711 Shark cartilage extracts and use thereof for immunomodulation |
| 08/11/2005 | US20050175640 Cyclodextrin and adrenocortical steroid dissolved in aqueous solution; dextran or pullulan; mixture with xyloglucan, trehalose, laminaran, pectin, and krestin; grape sugar, mutan, lentinan, sodium chloride, and/or potassium chloride; side effect reduction; psoriasis, atopic diseases |
| 08/11/2005 | US20050175621 Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form |
| 08/11/2005 | US20050175580 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
| 08/11/2005 | US20050175539 Compositions inhibiting rejection in organ transplantation and method of using the same |
| 08/11/2005 | CA2758323A1 Use of amino-oxy functional groups in the preparation of vaccines |
| 08/11/2005 | CA2553987A1 Method for producing maca extract |
| 08/10/2005 | EP1561759A1 Cell death-inducing agent |
| 08/10/2005 | EP1561751A1 Fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals |
| 08/10/2005 | EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases |
| 08/10/2005 | EP1560855A1 Polysaccharide of echinacea angustifolia |
| 08/10/2005 | EP1560850A2 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 08/10/2005 | EP1560834A1 New tricyclic derivatives as ltd4 antagonists |
| 08/10/2005 | EP1560830A2 Derivatives of [6, 7 - dihydro - 5h - imidazo [1,2 - a] imidazole - 3 - sulfonylamino]- propionamide and their use as inhibitors upon the interaction of cams and leukointegrins |
| 08/10/2005 | EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 08/10/2005 | EP1560811A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 08/10/2005 | EP1560592A1 Treatment of hypersensitivity conditions |
| 08/10/2005 | EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 08/10/2005 | EP1560579A1 Cholesterol absorption inhibitors for the treatment of autoimmune disorders |
| 08/10/2005 | EP1560562A2 Dermastick thickened ointment |
| 08/10/2005 | EP1471919B1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist |
| 08/10/2005 | EP1399406B1 Novel estrogen receptor ligands and methods i |
| 08/10/2005 | EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors |
| 08/10/2005 | EP1343826B1 Polysaccharide compound having immune stimulating activity |
| 08/10/2005 | EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 08/10/2005 | EP1208103B1 Reverse-turn mimetics and methods relating thereto |
| 08/10/2005 | EP1051189B1 Vaccine formulation comprising sugar-alcohols and low concentrations of anorganic ions |
| 08/10/2005 | EP0939652B1 Use of antibodies to cd45ro leukocyte antigen for immunomodulation |
| 08/10/2005 | EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 08/10/2005 | EP0794797B1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 08/10/2005 | EP0597852B2 Swine pneumonia vaccine and method for the preparation thereof |
| 08/10/2005 | CN1653182A Recombinant fowlpox virus |
| 08/10/2005 | CN1653089A Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 08/10/2005 | CN1653086A Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis C virus |
| 08/10/2005 | CN1653068A Novel diazabicyclic biaryl derivatives |
| 08/10/2005 | CN1653059A Macrocyclic compounds useful as pharmaceuticals |
| 08/10/2005 | CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 08/10/2005 | CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 08/10/2005 | CN1653040A HIF hydroxylase inhibitors |
| 08/10/2005 | CN1653032A Substituted phenylalkanoic acid derivatives and use thereof |
| 08/10/2005 | CN1652843A Methods for the treatment of respiratory diseases and conditions using a selective iNOS inhibitor |
| 08/10/2005 | CN1652820A Methods of treatment using CTLA-4 antibodies |
| 08/10/2005 | CN1652814A Induction of antigen specific immunologic tolerance |
| 08/10/2005 | CN1652810A Immunosuppressant compounds, methods and uses related thereto |
| 08/10/2005 | CN1652808A Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic |
| 08/10/2005 | CN1652805A An herbal composition for the treatment and remedy of bronchial respiratory difficulties |